| [1] |
Chen C, Xia HS, Gong YP, et al. The quantitative detection of total HER2 load by quantum dots and the identifi cation of a new subtype of breast cancer with different 5-year prognosis[J]. Bioma terials,2010,31(33):8818-25.
|
| [2] |
Bauer KR,Brown M,Cress RD,et a1.Descriptive analysis of estrogen receptor(ER)-negative, progesterone receptor(PR)- negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry[J]. Cancer,2007,109(9):1721-8.
|
| [3] |
Rakha EA,El-Sayed ME,Green AR.Prognostic markers in triplenegative breast cancer[J]. Cancer,2007,109(1):25-32.
|
| [4] |
Nielsen TO,Hsu FD,Jensen K,et a1.Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma[J]. C1in Cancer Res,2004,10(16):5367-74.
|
| [5] |
Dent R,Trudeau M,Pritchard KI,et a1.Triple-negative breast cancer:clinical features and patterns of recurrence[J]. Clin Cancer Res,2007,13(15 Pt 1):4429-34.
|
| [6] |
Thompson EW, Newgreen DF, Tarin D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?[J]. Cancer Res, 2005, 65(14) : 5991- 95.
|
| [7] |
Hugo H, Ackland ML, Blick T, et al. Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression[J]. J Cell Physiol. 2007, 213(2):374-83.
|
| [8] |
Baumgart E, Cohen MS, Silva Neto B, et al. Identification and prognostic significance of an epithelial-mesenchymal transition expression profi le in human bladder tumors[J]. Clin Cancer Res, 20 07, 13(6): 1685-94.
|
| [9] |
Aamodt R, Bondi J, Andersen SN, et al. The prognostic impact of protein expression of E-cadherin-catenin complexes differs between rectal and colon carcinoma[J]. Gastroenterol Res Pract, 20 10,2010.
|
| [10] |
Kang H, Min BS, Lee KY, et al. Loss of E-cadherin and MUC2 expressions correlated with poor survival in patients with stages Ⅱ and Ⅲ colorectal carcinoma[J]. Ann Surg Oncol, 2010, 18(3): 71 1-9.
|
| [11] |
Chelidonis G, Kavantzas N, Patsouris E, et al. DNA ploidy, E-cadherin, beta-catenin expression and their clinicopathologic signifi cance in imprints of non-small cell lung cancer[J]. Anal Quant Cytol Histol, 2009, 31(5): 332-9.
|
| [12] |
Moody SE, Perez D, Pan TC, et al. The transcriptional repressor Snail promotes mammary tumor recurrence[J]. Cancer Cell, 2005, 8( 3): 197-209.
|
| [13] |
Willipinski-Stapelfeldt B, Riethdorf S, Assmann V, et al. Changes in cytoskeletal protein composition indicative of an epithelialmesenchymal transition in human micrometastatic and primary breast carcinoma cells[J]. Clin Cancer Res, 2005, 11(22): 8006-14.
|
| [14] |
Gong YP,Qi CB,Wang MW,et al.Prognosis of triple-negative breast cancer and its relevance to epithelial-mesenchymal transitions[J]. Zhong Liu Fang Zhi Yan Jiu,2012,39(2):173-6.[龚益平,漆楚波, 王明伟,等.三阴性乳腺癌的预后与上皮间叶转化的相关性[J]. 肿瘤防治研究,2012,39(2):173-6.]
|
| [15] |
Wu Y,Li M,Tian YZ,et al.The expression of CD44v6 and E-cadherin are related with prognosis in invasive breast cancer[J]. Zhong Liu Fang Zhi Yan Jiu,2006,33(11):791-4.[吴岳,李敏,田育 璋,等.CD44v6、E-cadherin表达与乳腺浸润性癌预后的关系 [J] 肿瘤防治研究,2006,33(11):791-4.]
|
| [16] |
Lou Y, Preobrazhenska O, auf dem Keller U, et al. Epithelialmesenchymal transition (EMT) is not suffi cient for spontaneous murine breast cancer metastasis[J]. Dev Dyn, 2008, 237(10): 27 55-68.
|
下载:
